Tiffany A. Traina
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 54
- HER2/EGFR in Cancer Research 22
- Cancer Treatment and Pharmacology 18
- PARP inhibition in cancer therapy 9
-
- Breast Cancer Treatment Studies 30
- Cancer Genomics and Diagnostics 8
- Co-authors
- Ayca Gucalp (18 shared papers)Clifford A. Hudis (22 shared papers)Sujata N Patil (14 shared papers)Larry Norton (17 shared papers)William L. Gerald (2 shared papers)Eric P. Winer (4 shared papers)Karen Anne Cadoo (4 shared papers)Hope S. Rugo (9 shared papers)
- Journals
- Breast Cancer Research and Treatment (13 papers)Clinical Cancer Research (11 papers)Journal of Clinical Oncology (10 papers)Clinical Breast Cancer (7 papers)Annals of Oncology (7 papers)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Tiffany A. Traina
110 papers receiving 9.4k citations
Tiffany A. Traina's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 3.2k
- Oncology 4.1k
- Pulmonary and Respiratory Medicine 2.6k
- Pathology and Forensic Medicine 704
- Genetics 1.1k
Countries citing papers authored by Tiffany A. Traina
This map shows the geographic impact of Tiffany A. Traina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany A. Traina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany A. Traina more than expected).
Fields of papers citing papers by Tiffany A. Traina
This network shows the impact of papers produced by Tiffany A. Traina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany A. Traina. The network helps show where Tiffany A. Traina may publish in the future.
Co-authors
The 25 scholars most cited alongside Tiffany A. Traina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | OncoKB: A Precision Oncology Knowledge Base Hit paper breakdown → | 2017 | 1972 |
| 2 | Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer Hit paper breakdown → | 2021 | 1197 |
| 3 | The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers Hit paper breakdown → | 2018 | 761 |
| 4 | Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer Hit paper breakdown → | 2013 | 603 |
| 5 | Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer Hit paper breakdown → | 2018 | 396 |
| 6 | 2015 | 350 | |
| 7 | 2009 | 341 | |
| 8 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 321 |
| 9 | Male breast cancer: a disease distinct from female breast cancer Hit paper breakdown → | 2018 | 263 |
| 10 | Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study Hit paper breakdown → | 2021 | 196 |
| 11 | 2009 | 186 | |
| 12 | 2014 | 141 | |
| 13 | 2011 | 125 | |
| 14 | 2013 | 119 | |
| 15 | 2015 | 116 | |
| 16 | 2010 | 112 | |
| 17 | 2013 | 106 | |
| 18 | 2014 | 85 | |
| 19 | 2015 | 78 | |
| 20 | 2010 | 77 |
About Tiffany A. Traina
Tiffany A. Traina is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 114 papers that have together received 9.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (22 papers), Advanced Breast Cancer Therapies (22 papers), Cancer Treatment and Pharmacology (18 papers), Estrogen and related hormone effects (11 papers), PARP inhibition in cancer therapy (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer-related cognitive impairment studies (7 papers). The work is most often cited by research in Cancer Research (3.2k citations), Oncology (4.1k citations), Pulmonary and Respiratory Medicine (2.6k citations), Pathology and Forensic Medicine (704 citations) and Genetics (1.1k citations). Tiffany A. Traina has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Ayca Gucalp, Clifford A. Hudis, Sujata N Patil, Larry Norton, William L. Gerald, Eric P. Winer, Karen Anne Cadoo, Hope S. Rugo, ANTHONY D. ELIAS and Kevin M. Kalinsky. Their work appears in journals such as Breast Cancer Research and Treatment, Clinical Cancer Research, Journal of Clinical Oncology, Clinical Breast Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.